Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

May 16, 2014 by Alan Khadavi

Stepwise approach to Chronic Urticaria (Chronic Hives)

Chronic hives affects up to 1.0% of the U.S. population.  It is also known as chronic idiopathic urticaria or chronic spontaneous urticaria or chronic autoimmune urticaria.  It can often last up to 5 years (80%) or more (20%).  Its highest incidence is between 20 and 40 years of age and woman outnumber men (2:1).

Chronic hives is associated with poor sleep and reduced quality of life.  Many of the medications used to treat hives (first generation antihistamines, i.e. benadryl, hydroxyzine) cause severe sedation.  Others such as Doxepin work very well to control hives, but common side effects are lethargy, dry mouth and constipation.

Recent stepwise guidelines were published by the Annals of Asthma, Allergy and Immunology regarding the treatment of Chronic Urticaria (chronic hives).   Most of the treatment discussed below will apply to patients who have chronic idiopathic urticaria.  These are people who get hives for greater than 6 weeks duration with no cause found.  Another term for chronic idiopathic urticaria (CIU) that is being used is, chronic spontaneous urticaria (CSU).

We spoke about hives in a previous post.

https://allergylosangeles.com/allergy-blog/hives-urticaria/

The literature was reviewed and current recommendations are listed below.

All patients: Avoidance of triggers

Step 1– Nonsedating second or third generation antihistamines taken up to 4 times a day. (i.e. Claritin, Zyrtec, Allegra, Xyzal, Clarinex) Decrease the dose as tolerated.

Step 1B-Montelukast (Singulair) and ranitidine (Zantac) (now off market, Pepcid is an alternative) are not first line, placebo controlled studies are not conclusive for using them  Although some patients have benefitted from adding these meds to anti-histamines.  Anecdotally, some patients have seen benefit from using them.

Patient response to step 1 is approximately 45%

Step 1C- Depending on which guidelines are followed, a potent antihistamine (i.e. doxepin or hydroxyzine) can be added. Of note, these medications can cause sedation and should be dosed initially at nighttime.

Step 2– Omalizumab 300 mg monthly (Xolair).  If no response after 3 injections, (some studies say up to 6 injections) proceed to step 3.

Response of hives after treatment with Xolair

https://allergylosangeles.com/allergy-blog/xolair-omalizumab-for-chronic-urticaria/

Patient response to step 1 and 2 is 80%.

Step 3– Cyclosporine, 200-300mg a day.  For this step, patients need to have their blood urea nitrogen, creatine, urinanalysis and blood pressure checked at the onset, which is repeated in 4-6 week intervals.  Cyclosporine is contraindicated in hypertension and patients with compromised renal function.  Effect is typically seen within 1 week, it can usually be tapered after a few quiescent months.

Patient response after step 3 is 93%.

Step 4-Options to consider are dapsone, methotrexate, colchicine, sulfasalazine, hydroxychloroquine, IVIG and plasmapheresis.  To learn more about alternative options, click here Alternative Agents for Refractory Chronic Urticaria Patients

Step 5- If all options fail, low dose, long term corticosteroids may be considered for chronic hives.

Chronic hives can be a difficult disease to treat.  Studies have shown that many case have no known cause (idiopathic). At that point the chronic hives are treated with medications to reduce the occurrence.  It can be very frustrating for both the physician and the patient as to what is causing the hives to break out daily.  Fortunately if the medication guidelines are followed as described above, many times the chronic hives can be well controlled and in many patients spontaneous resolution may occur.

The diagnostic evaluation of chronic hives can consist of a CBC, ESR/CRP, Thyroid panel, thyroid antibodies, ANA, IgG antibody to the alpha subunit of the IgE receptor.  There is some controversy whether or not to test liver or renal function for chronic hives.  Skin biopsy is performed if the lesions are not clearly hives (possibly cutaneous vasculitis), the lesions last longer than 24 hours, presence of petechiae or purpura or if there is arthralgia, arthritis, fever or any involvement of other organ systems.

Research is still ongoing as to the possible causes of chronic hives, but still to this day a definitive cause for them has not been found in many patients.  Chronic idiopathic urticaria is very hard to manage for most patients, it is best to speak with your allergist or allergy doctor what the best course of treatment is for you.

For more information on hives, please see the articles below.

Alternative Agents for Refractory Chronic Urticaria Patients

Altered Gut Microbes in Chronic Hives

Systemic Complaints in Chronic Urticaria (hives)

Update 12/03/2021

In a recent study titled “Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE”, researchers findings were that elevated aTPO (IgG anti-thyroid peroxidase), low total IgE levels, is a useful diagnostic maker for Autoimmune chronic spontaneous urticaria in everyday clinical practice. This is also associated with resistance to antihistamine treatment.

There even seems to be 2 types of autoimmune mechanisms. Type 1 autoimmune (autoallergic) is associated with IgE antibodies against autoantigens, for example, thyroid peroxidase and IL-24. Type 2b autoimmune CSU is mediated by autoantibodies that activate mast cells, for example, via IgE and Fc epsilon R1, and is present in less than 10% with CSU. Patients can have either type or both. As endotypes, type 1 and type 2b autoimmune chronic spontaneous urticaria may differ in disease course, clinical features and response to treatment.

 

 

 

Filed Under: Blog, Urticaria

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

January 22, 2023

Is Benadryl Safe to use, or is it Time to Move on?

is benadryl safe

January 12, 2023

Airsupra for Asthma, a new rescue medication

airsupra

December 26, 2022

Cantaloupe Allergy comes in many flavors

cantaloupe allergy

December 23, 2022

Remibrutinib, a BTK inhibitor for Chronic Hives

remibrutininb

November 21, 2022

Eczema and Hard Water, is there a link?

eczema and hard water

November 19, 2022

Nucala, Fasenra or Dupixent for Severe Eosinophilic Asthma?

nucala fasenra dupixent

November 18, 2022

Xolair for idiopathic angioedema

xolair for idiopathic angioedema

September 29, 2022

When will my child outgrow egg allergy?

outgrow egg allergy

September 13, 2022

Can you be allergic to water? (Aquagenic Urticaria)

allergic to water

September 8, 2022

Oclacitinib for Atopic Dermatitis (Eczema) in Dogs

oclacitinib

Read More Posts...

Follow Us…

© 2023 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page